Hunter C Smith
Chief Financial Officer · 6 filings · Latest: May 18, 2026
RHYTHM PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RYTM | Hunter C Smith | Chief Financial Officer | May 18, 2026 | Option Exercise | $17.87 | 3,000 | $53.6K | 119,611 | |
RYTM | Hunter C Smith | Chief Financial Officer | Mar 2, 2026 | Option Exercise | $6.80 | 6,099 | $41.5K | 116,611 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 19, 2026 | Sale | $101.26 | 4,385 | $444.0K | 110,512 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 17, 2026 | Sale | $101.38 | 3,569 | $361.8K | 114,897 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 12, 2026 | Sale | $98.23 | 1,592 | $156.4K | 118,466 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 11, 2026 | Sale | $98.61 | 2,766 | $272.8K | 120,058 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 10, 2026 | Sale | $103.00 | 2,713 | $279.4K | 122,824 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 5, 2026 | Sale | $106.06 | 3,381 | $358.6K | 125,537 | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 4, 2026 | Sale | $105.99 | 3,247 | $344.1K | 128,918 | |
RYTM | HUNTER SMITH | — | Feb 5, 2026 | Proposed Sale | $107.97 | 18,406 | $2.0M | — | |
RYTM | HUNTER SMITH | — | Feb 4, 2026 | Proposed Sale | $108.29 | 3,247 | $351.6K | — | |
RYTM | Hunter C Smith | Chief Financial Officer | Feb 1, 2026 | Option Exercise | — | 26,000 | — | 142,915 | |
RYTM | HUNTER SMITH | — | Aug 12, 2025 | Proposed Sale | $94.31 | 28,088 | $2.6M | — | |
RYTM | HUNTER SMITH | — | Jul 9, 2025 | Proposed Sale | $65.14 | 42,120 | $2.7M | — | |
RYTM | HUNTER SMITH | — | May 30, 2025 | Proposed Sale | $61.88 | 23,400 | $1.4M | — |